Pepticom
Latest round
- Series A
Last raised
- Oct 2019
Total raised
- $5M
Investors
- 1
About Pepticom
Founded in 2011 in Jerusalem, Israel, Pepticom Ltd. specializes in AI-driven peptide therapeutics.Pepticom specializes in developing innovative peptide therapeutics using advanced AI technologies. Their products focus on designing and optimizing therapeutic peptides to target previously undruggable medical conditions, specifically for treating plaque psoriasis through oral IL-17 inhibitors. The company's proprietary computational AI platform facilitates the rapid prototyping of peptide candidates, utilizing both natural and synthetic amino acids while integrating reinforcement learning to enhance therapeutic efficacy and bioavailability.Pepticom generates revenue through strategic partnerships, collaborations, and licensing agreements with major pharmaceutical companies. These partnerships involve tailored peptide design services and licensing of proprietary technologies for drug discovery.In January 2024, Pepticom Ltd. The company plans to develop new peptide therapeutics targeting additional unmet medical needs and expand its market presence into North America, Europe, and Asia by 2025, leveraging its AI platform to increase the efficiency and effectiveness of its drug development process.
Who invested in Pepticom
1 investor across 1 round
See all investors in Pepticom
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 24, 2019
Amount
$5M
Investors
Questions about Pepticom
Who invested in Pepticom?
Pepticom has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pepticom raised?
Pepticom has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Pepticom last raise money?
Pepticom's most recent round on record is a Series A, in Oct 2019.
What does Pepticom do?
Founded in 2011 in Jerusalem, Israel, Pepticom Ltd.
Where is Pepticom headquartered?
Pepticom is headquartered in Jerusalem, Israel.
Which VCs invest in companies like Pepticom?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Pepticom's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Pepticom? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.